Cite
Effect of hepatic and renal impairment on the pharmacokinetics of olanzapine and samidorphan given in combination as a bilayer tablet
MLA
Sun L, et al. “Effect of Hepatic and Renal Impairment on the Pharmacokinetics of Olanzapine and Samidorphan given in Combination as a Bilayer Tablet.” Drug Design, Development and Therapy, Aug. 2019, pp. 2941–55. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doajarticles..08d9d9702eefe6357339d4ed56fe83e0&authtype=sso&custid=ns315887.
APA
Sun L, Yagoda S, Du Y, & von Moltke L. (2019). Effect of hepatic and renal impairment on the pharmacokinetics of olanzapine and samidorphan given in combination as a bilayer tablet. Drug Design, Development and Therapy, 2941–2955.
Chicago
Sun L, Yagoda S, Du Y, and von Moltke L. 2019. “Effect of Hepatic and Renal Impairment on the Pharmacokinetics of Olanzapine and Samidorphan given in Combination as a Bilayer Tablet.” Drug Design, Development and Therapy, August, 2941–55. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doajarticles..08d9d9702eefe6357339d4ed56fe83e0&authtype=sso&custid=ns315887.